135 related articles for article (PubMed ID: 15767973)
21. Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity.
Pollock K; Stebbing J; Bower M; Gazzard B; Nelson M
J Antimicrob Chemother; 2006 Jul; 58(1):227-8. PubMed ID: 16684800
[No Abstract] [Full Text] [Related]
22. [New fixed combination for HIV therapy].
Krankenpfl J; 2005; 43(4-6):95. PubMed ID: 16171046
[No Abstract] [Full Text] [Related]
23. Truvada intolerance.
Vemuri S; Bratberg J; Burke K; Skowron G
AIDS; 2007 Jan; 21(3):382-3. PubMed ID: 17255751
[No Abstract] [Full Text] [Related]
24. Generic Truvada approved.
AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
[No Abstract] [Full Text] [Related]
25. Efficacy of tenofovir-emtricitabine versus abacavir-lamivudine.
Landman GW; Soonawala D
Clin Infect Dis; 2010 Apr; 50(8):1200; author reply 1200. PubMed ID: 20233045
[No Abstract] [Full Text] [Related]
26. Combination antiretroviral therapy with tenofovir, emtricitabine or lamivudine, and nevirapine.
Redfield RR; Morrow JS
Clin Infect Dis; 2008 Oct; 47(7):984-5. PubMed ID: 18778234
[No Abstract] [Full Text] [Related]
27. Trial will evaluate a once-daily dose of raltegravir.
AIDS Patient Care STDS; 2008 Nov; 22(11):918-9. PubMed ID: 19043842
[No Abstract] [Full Text] [Related]
28. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
29. A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate.
De Clercq E
Expert Opin Pharmacother; 2009 Dec; 10(17):2935-7. PubMed ID: 19929712
[TBL] [Abstract][Full Text] [Related]
30. Treatment options for HIV, AIDS.
FDA Consum; 2004; 38(6):4. PubMed ID: 15675011
[No Abstract] [Full Text] [Related]
31. Anti-HIV drugs.
De Clercq E
Verh K Acad Geneeskd Belg; 2007; 69(2):81-104. PubMed ID: 17550060
[TBL] [Abstract][Full Text] [Related]
32. [New fixed once daily combination as nucleoside backbone. Basis for long-term therapy success].
MMW Fortschr Med; 2005 Apr; 147 Spec No 1():66-8. PubMed ID: 16385881
[No Abstract] [Full Text] [Related]
33. Boosted versus unboosted indinavir with zidovudine and lamivudine in nucleoside pre-treated patients: a randomized, open-label trial with 112 weeks of follow-up (HIV-NAT 005).
Boyd MA; Srasuebkul P; Khongphattanayothin M; Ruxrungtham K; Hassink EA; Duncombe CJ; Ubolyam S; Burger DM; Reiss P; Stek M; Lange J; Cooper DA; Phanuphak P
Antivir Ther; 2006; 11(2):223-32. PubMed ID: 16640103
[TBL] [Abstract][Full Text] [Related]
34. Transmission. Company halts Truvada PrEP for women study.
AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
[No Abstract] [Full Text] [Related]
35. Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.
Blackwell CW
Nurse Pract; 2014 Sep; 39(9):50-3. PubMed ID: 25140852
[TBL] [Abstract][Full Text] [Related]
36. [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
Marcus U
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():42-4. PubMed ID: 23961656
[No Abstract] [Full Text] [Related]
37. HIV study yields unexpected preliminary efficacy results.
Traynor K
Am J Health Syst Pharm; 2008 Apr; 65(8):686-8. PubMed ID: 18387889
[No Abstract] [Full Text] [Related]
38. Bioequivalent formulation for the fixed-dose regimen of Truvada and TMC278 finalized.
AIDS Patient Care STDS; 2010 Jun; 24(6):395-6. PubMed ID: 20575158
[No Abstract] [Full Text] [Related]
39. Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan.
Kurita T; Kitaichi T; Nagao T; Miura T; Kitazono Y
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):372-81. PubMed ID: 24590575
[TBL] [Abstract][Full Text] [Related]
40. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
Cohen J
Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
